Format

Send to

Choose Destination
Oncotarget. 2019 Nov 5;10(60):6432-6443. doi: 10.18632/oncotarget.27266. eCollection 2019 Nov 5.

The anti-cancer effects of phenformin in thyroid cancer cell lines and in normal thyrocytes.

Author information

1
Istituti Clinici Scientifici Maugeri IRCCS, Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors, Pavia, Italy.
2
PHD course in Experimental Medicine, University of Pavia, Pavia, Italy.
3
Molecular Cardiology, ICS-Maugeri, Pavia, Italy.
4
Department of Biopharmaceutics and Clinical Pharmacy, The University of Jordan, Amman, Jordan.
5
Department of General and Minimally Invasive Surgery, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
6
Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.

Abstract

Phenformin is a biguanide drug which, besides the original anti-diabetic effect, also exerts anti-cancer effects. The aim of this study was to further characterize these latter in terms of both cell-viability and modulation of the secretion of the pro-tumorigenic chemokine CXCL8. Normal human thyrocytes in primary cultures (NHT) and thyroid cancer cell lines, TPC-1 and 8505C (RET/PTC and BRAFV600E mutated, respectively) were treated with increasing concentrations of phenformin at different times. Cell-viability was assessed by WST-1 and further characterized by AnnexinV/PI staining and cell proliferation colony-assay. CXCL8 levels were measured in cell supernatants. Phenformin reduced cell-viability in TPC-1 and 8505C and their ability to form colonies. In NHT cells, phenformin affected cell-viability only at the maximal dose but interestingly it inhibited CXCL8 secretion at all the concentrations not affecting cell-viability. Phenformin had no effect on CXCL8 secretion in thyroid cancer cell lines. Thus, phenformin exerts anti-cancer effects on both cancer cells (cell death induction) and surrounding normal cells (inhibition of CXCL8 secretion). These results highlight that the anti-cancer effects of phenformin are multifaceted and effective on both solid and soluble components of the tumor-microenvironment.

KEYWORDS:

CXCL8; phenformin; thyroid cancer; tumor-microenvironment

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center